Advanced Biomed Inc. shares fall 12.97% intraday despite launching A+PerfusC™ 3D cell culture system.

Advanced Biomed Inc. dropped 12.97% intraday, despite the company announcing the launch of its A+PerfusC™ system, a compact, all-in-one perfusion 3D cell culture incubator designed to replicate human physiological conditions in vitro. The system integrates automated perfusion with environmental control in a compact format that can be mounted directly onto a microscope for real-time observation, supporting up to 12 days of continuous, hands-free culture.